Venook AP - Search Results

1

Plasma Protein Biomarkers in Advanced or Metastatic Colorectal Cancer Patients Receiving Chemotherapy With Bevacizumab or Cetuximab: Results from CALGB 80405 (Alliance).

Nixon AB, Sibley AB, Liu Y, Hatch AJ, Jiang C, Mulkey F, Starr MD, Brady JC, Niedzwiecki D, Venook AP, Baez-Diaz L, Lenz HJ, O'Neil BH, Innocenti F, Meyerhardt JA, O'Reilly EM, Owzar K, Hurwitz HI. Nixon AB, et al. Among authors: venook ap. Clin Cancer Res. 2022 Jul 1;28(13):2779-2788. doi: 10.1158/1078-0432.CCR-21-2389. Clin Cancer Res. 2022. PMID: 34965954 Free PMC article.

2

Alternating hepatic intra-arterial floxuridine and fluorouracil: a less toxic regimen for treatment of liver metastases from colorectal cancer.

Stagg RJ, Venook AP, Chase JL, Lewis BJ, Warren RS, Roh M, Mulvihill SJ, Grobman BJ, Rayner AA, Hohn DC. Stagg RJ, et al. Among authors: venook ap. J Natl Cancer Inst. 1991 Mar 20;83(6):423-8. doi: 10.1093/jnci/83.6.423. J Natl Cancer Inst. 1991. PMID: 1825674 Clinical Trial.

3

Regional chemotherapy for colorectal cancer metastatic to the liver.

Venook AP, Stagg RJ, Lewis BJ. Venook AP, et al. Oncology (Williston Park). 1988 Mar;2(3):19-26. Oncology (Williston Park). 1988. PMID: 3079322 Review.

4

Regional chemotherapy approaches for primary and metastatic liver tumors.

Venook AP, Warren RS. Venook AP, et al. Surg Oncol Clin N Am. 1996 Apr;5(2):411-427. Surg Oncol Clin N Am. 1996. PMID: 9019361 Review.

5

Induction therapy in patients with metastatic colorectal cancer.

Venook AP. Venook AP. Semin Oncol. 2003 Aug;30(4 Suppl 12):25-9. doi: 10.1016/s0093-7754(03)00331-2. Semin Oncol. 2003. PMID: 14508724 Review. No abstract available.

6

Fractional genomic alteration detected by array-based comparative genomic hybridization independently predicts survival after hepatic resection for metastatic colorectal cancer.

Mehta KR, Nakao K, Zuraek MB, Ruan DT, Bergsland EK, Venook AP, Moore DH, Tokuyasu TA, Jain AN, Warren RS, Terdiman JP, Waldman FM. Mehta KR, et al. Among authors: venook ap. Clin Cancer Res. 2005 Mar 1;11(5):1791-7. doi: 10.1158/1078-0432.CCR-04-1418. Clin Cancer Res. 2005. PMID: 15756001

7

Critical evaluation of current treatments in metastatic colorectal cancer.

Venook A. Venook A. Oncologist. 2005 Apr;10(4):250-61. doi: 10.1634/theoncologist.10-4-250. Oncologist. 2005. PMID: 15821245 Free article. Review.

8

Epidermal growth factor receptor-targeted treatment for advanced colorectal carcinoma.

Venook AP. Venook AP. Cancer. 2005 Jun 15;103(12):2435-46. doi: 10.1002/cncr.21123. Cancer. 2005. PMID: 15880563 Free article. Review.

9

Cetuximab in the treatment of colorectal cancer.

Goldberg RM, Venook AP, Schilsky RL. Goldberg RM, et al. Among authors: venook ap. Clin Adv Hematol Oncol. 2004 Nov;2(11):1-10; quiz 11-12. Clin Adv Hematol Oncol. 2004. PMID: 16170891 No abstract available.

10

Phase II study of fixed dose rate gemcitabine with cisplatin for metastatic adenocarcinoma of the pancreas.

Ko AH, Dito E, Schillinger B, Venook AP, Bergsland EK, Tempero MA. Ko AH, et al. Among authors: venook ap. J Clin Oncol. 2006 Jan 20;24(3):379-85. doi: 10.1200/JCO.2005.01.8267. Epub 2005 Dec 12. J Clin Oncol. 2006. PMID: 16344320 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

328 results

Search Page